Suzhou (1)

Refractory and Relapsed T Cell Lymphoma (1)

Recruiting (1)

phase 2 (1)

The First Affiliated Hospital of Soochow University (1)

Affiliated Hospital of Jiangnan University (1)

PersonGen BioTherapeutics (Suzhou) Co., Ltd. (1)

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)

The Affiliated Zhongshan Hospital of Dalian University (1)

The First Affiliated Hospital of Dalian Medical University (1)

humanized cd7 car-t cells (1)

biological (1)

Other (1)

Interventional (1)

refractory and relapsed t cell lymphoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Sep 17, 2021